This phase II study evaluates the feasibility and acceptability of a weight loss program via telehealth among women who have been treated for breast cancer. Telehealth via video conferencing is an effective and efficient means of communicating with and supporting patients who live in diverse geographic communities, travel long distances to receive cancer care, cannot meet in a central location, or have ongoing medical problems. Weight loss intervention using a multi-media telehealth format may enhance the outcomes currently seen with telephone-based interventions.
Additional locations may be listed on ClinicalTrials.gov for NCT04855552.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To determine the feasibility and acceptability of a weight loss program via telehealth for breast cancer survivors. Several surveys will be conducted pre-and post-intervention to assess acceptability.
SECONDARY OBJECTIVE:
II. To explore possible changes from pre-to-post weight-loss intervention for 1) body mass (percent weight loss) and 2) mammographic breast density (MBD).
OUTLINE:
Patients receive lifestyle counseling for 20 weeks, followed by a session during weeks 22 and 24, for a total of 6 months. Patients undergo physical activity (e.g., brisk walking, swimming), for 30 minutes up to five days a week for 6 weeks. Patients complete a pre and post-intervention questionnaire and their medical records are reviewed.
After the completion of the study treatment, patients are followed up every 6 months or yearly by their oncology team.
Lead OrganizationUniversity of Pennsylvania/Abramson Cancer Center
Principal InvestigatorJulia C. Tchou
